Loading clinical trials...
Loading clinical trials...
Neuropsychology and Personality: Personality Traits as a Variable in the Recovery of Patients With Acquired Brain Injury
This study aims to evaluate the potential effects of premorbid personality on the short- and long-term global cognitive recovery in patients with severe acquired brain injury (sABI) or stroke. The secondary aims are to assess the effects of premorbid personality on the sort- and long-term recovery in autonomy (disability), cognitive functions, psycho-behavioral functioning, motor skills, and social participation. Evaluate the incidence of premorbid personality alterations. Investigate personality changes 12-18 months after the neurological event.
Participants included in the study will undergo cognitive, motor, psychological, behavioral, personality, and disability assessments at different time points following the neurological event: T0: Initial assessment upon admission to the rehabilitation facility; within 90 days of the event for patients with severe acquired brain injury (sABI), as soon as cognitive evaluation becomes feasible (LCF ≥ 6); within 30 days of the event for stroke patients, as soon as cognitive assessment is possible. T1: At discharge from the inpatient rehabilitation program, provided that at least 30 days have passed since the initial assessment (T0). T2: At 12 months post-event for stroke patients and at 18 months post-event for patients with ABI.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Sezione medicina fisica e riabilitativa dipartimento di neuroscienze, verona
Verona, VR, Italy
Start Date
May 1, 2025
Primary Completion Date
May 1, 2028
Completion Date
May 1, 2028
Last Updated
August 13, 2025
250
ESTIMATED participants
Motor, cognitive and psychological assessment
DIAGNOSTIC_TEST
Lead Sponsor
Universita di Verona
Collaborators
NCT07360600
NCT06019182
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions